Tuesday Jul 8
Pluristem Therapeutics Initiates South Korean Arm of Multinational...
Pluristem Therapeutics Inc. , a leading developer of placenta-based cell therapies, today announced the initiation of South Korean sites in the Phase II study assessing PLacental eXpanded cells in the treatment of intermittent claudication .
Six-Minute Walk Is a Better Outcome Measure Than Treadmill Walking...
From the Departments of Medicine , Preventive Medicine , and Surgery , Northwestern University's Feinberg School of Medicine, Chicago, IL; Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore ; Department of Family and Preventive Medicine University of California at San Diego, San Diego ; and ... (more)